NCT06116253View on ClinicalTrials.gov

Advanced Diffusion Imaging in Renal Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions
Renal Cancer
Interventions
DEVICE

Magnetic Resonance Imaging (MRI) Scan

Participants will undergo a 1-hour research MRI scan.

DRUG

Tc-99m Pentetate

Participants will receive radioisotope (99mTc-DTPA) injection (5 mCi) during 3-5 hour scanning session to estimate measured glomerular filtration rate (mGFR).

Trial Locations (1)

10016

RECRUITING

NYU Langone Health, New York

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

NYU Langone Health

OTHER